Less than a tenth of people diagnosed with glioblastoma survive five years after diagnosis. That might be changing. German Biotech company CeGaT has developed a promising treatment for the deadly brain cancer by sequencing a unique vaccine from a patient’s cancer cells.
Host Indira Lakshmanan breaks down the process with Saskia Biskup, co-founder of CeGaT, and American patient Laura Eddington, who was joined by her husband, Jeff Eddington.
This article was originally published on WBUR.org.
Copyright 2026 WBUR
